Mostrando 702,441 - 702,460 Resultados de 703,879 Para Buscar '"No limits"', tiempo de consulta: 4.29s Limitar resultados
  1. 702441
  2. 702442
    “…However, recent data about the up-to-date stroke burden in China are limited. OBJECTIVE: To investigate the urban-rural disparity of stroke burden in the Chinese adult population, including prevalence, incidence, and mortality rate, and disparities between urban and rural populations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 702443
  4. 702444
    “…CONCLUSION(S): This innovative and novel approach to HCV therapy in PWUD was able to successfully use a peer-based approach to find people with limited connection to primary health care to test and treat HCV. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 702445
    “…The assessment of TABUS in pediatric IBD has been limited to small numbers of patients with no long-term follow-up. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 702446
    “…Among all interventional techniques, de-epithelialization, in combination with chemical sealant, has a higher success rate than other techniques. However, due to the limited number of cases reported for implementing many kinds of techniques, an ideal endoscopic interventional technique has yet to be devised, often necessitating more treatment applications and close follow-up.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 702447
    por Acciarri, M., Achard, P., Adriani, O., Aguilar-Benitez, M., Alcaraz, J., Alemanni, G., Allaby, J., Aloisio, A., Alviggi, M.G., Ambrosi, G., Anderhub, H., Andreev, Valery P., Angelescu, T., Anselmo, F., Arefev, A., Azemoon, T., Aziz, T., Bagnaia, P., Bajo, A., Baksay, L., Balandras, A., Baldew, S.V., Banerjee, S., Banerjee, Sw., Barczyk, A., Barillere, R., Barone, L., Bartalini, P., Basile, M., Battiston, R., Bay, A., Becattini, F., Becker, U., Behner, F., Bellucci, L., Berbeco, R., Berdugo, J., Berges, P., Bertucci, B., Betev, B.L., Bhattacharya, S., Biasini, M., Biland, A., Blaising, J.J., Blyth, S.C., Bobbink, G.J., Bohm, A., Boldizsar, L., Borgia, B., Bourilkov, D., Bourquin, M., Braccini, S., Branson, J.G., Brigljevic, V., Brochu, F., Buffini, A., Buijs, A., Burger, J.D., Burger, W.J., Cai, X.D., Campanelli, Mario, Capell, M., Cara Romeo, G., Carlino, G., Cartacci, A.M., Casaus, J., Castellini, G., Cavallari, F., Cavallo, N., Cecchi, C., Cerrada, M., Cesaroni, F., Chamizo, M., Chang, Y.H., Chaturvedi, U.K., Chemarin, M., Chen, A., Chen, G., Chen, G.M., Chen, H.F., Chen, H.S., Chiefari, G., Cifarelli, L., Cindolo, F., Civinini, C., Clare, I., Clare, R., Coignet, G., Colino, N., Costantini, S., Cotorobai, F., Cozzoni, B., de la Cruz, B., Csilling, A., Cucciarelli, S., Dai, T.S., van Dalen, J.A., D'Alessandro, R., de Asmundis, R., Deglon, P., Degre, A., Deiters, K., della Volpe, D., Delmeire, E., Denes, P., DeNotaristefani, F., De Salvo, A., Diemoz, M., Dierckxsens, M., van Dierendonck, D., Di Lodovico, F., Dionisi, C., Dittmar, M., Dominguez, A., Doria, A., Dova, M.T., Duchesneau, D., Dufournaud, D., Duinker, P., Duran, I., El Mamouni, H., Engler, A., Eppling, F.J., Erne, F.C., Extermann, P., Fabre, M., Faccini, R., Falagan, M.A., Falciano, S., Favara, A., Fay, J., Fedin, O., Felcini, M., Ferguson, T., Ferroni, F., Fesefeldt, H., Fiandrini, E., Field, J.H., Filthaut, F., Fisher, P.H., Fisk, I., Forconi, G., Freudenreich, K., Furetta, C., Galaktionov, Iouri, Ganguli, S.N., Garcia-Abia, Pablo, Gataullin, M., Gau, S.S., Gentile, S., Gheordanescu, N., Giagu, S., Gong, Z.F., Grenier, Gerald Jean, Grimm, O., Gruenewald, M.W., Guida, M., van Gulik, R., Gupta, V.K., Gurtu, A., Gutay, L.J., Haas, D., Hasan, A., Hatzifotiadou, D., Hebbeker, T., Herve, Alain, Hidas, P., Hirschfelder, J., Hofer, H., Holzner, G., Hoorani, H., Hou, S.R., Hu, Y., Iashvili, I., Jin, B.N., Jones, Lawrence W., de Jong, P., Josa-Mutuberria, I., Khan, R.A., Kaur, M., Kienzle-Focacci, M.N., Kim, D., Kim, J.K., Kirkby, Jasper, Kiss, D., Kittel, W., Klimentov, A., Konig, A.C., Kopp, A., Koutsenko, V., Kraber, M., Kraemer, R.W., Krenz, W., Kruger, A., Kunin, A., Ladron de Guevara, P., Laktineh, I., Landi, G., Lassila-Perini, K., Lebeau, M., Lebedev, A., Lebrun, P., Lecomte, P., Lecoq, P., Le Coultre, P., Lee, H.J., Le Goff, J.M., Leiste, R., Leonardi, Emanuele, Levtchenko, P., Li, C., Likhoded, S., Lin, C.H., Lin, W.T., Linde, F.L., Lista, L., Liu, Z.A., Lohmann, W., Longo, E., Lu, Y.S., Lubelsmeyer, K., Luci, C., Luckey, David, Lugnier, L., Luminari, L., Lustermann, W., Ma, W.G., Maity, M., Malgeri, L., Malinin, A., Mana, C., Mangeol, D., Mans, J., Marchesini, P., Marian, G., Martin, J.P., Marzano, F., Mazumdar, K., McNeil, R.R., Mele, S., Merola, L., Meschini, M., Metzger, W.J., von der Mey, M., Mihul, A., Milcent, H., Mirabelli, G., Mnich, J., Mohanty, G.B., Molnar, P., Monteleoni, B., Moulik, T., Muanza, G.S., Muijs, A.J.M., Musy, M., Napolitano, M., Nessi-Tedaldi, F., Newman, H., Niessen, T., Nisati, A., Kluge, Hannelies, Organtini, G., Oulianov, A., Palomares, C., Pandoulas, D., Paoletti, S., Paolucci, P., Paramatti, R., Park, H.K., Park, I.H., Pascale, G., Passaleva, G., Patricelli, S., Paul, Thomas Cantzon, Pauluzzi, M., Paus, C., Pauss, F., Pedace, M., Pensotti, S., Perret-Gallix, D., Petersen, B., Piccolo, D., Pierella, F., Pieri, M., Piroue, P.A., Pistolesi, E., Plyaskin, V., Pohl, M., Pojidaev, V., Postema, H., Pothier, J., Prokofev, D.O., Prokofev, D., Quartieri, J., Rahal-Callot, G., Rahaman, M.A., Raics, P., Raja, N., Ramelli, R., Rancoita, P.G., Raspereza, A., Raven, G., Razis, P., Ren, D., Rescigno, M., Reucroft, S., Riemann, S., Riles, Keith, Robohm, A., Rodin, J., Roe, B.P., Romero, L., Rosca, A., Rosier-Lees, S., Rubio, J.A., Ruschmeier, D., Rykaczewski, H., Saremi, S., Sarkar, S., Salicio, J., Sanchez, E., Sanders, M.P., Sarakinos, M.E., Schafer, C., Schegelsky, V., Schmidt-Kaerst, S., Schmitz, D., Schopper, H., Schotanus, D.J., Schwering, G., Sciacca, C., Sciarrino, D., Seganti, A., Servoli, L., Shevchenko, S., Shivarov, N., Shoutko, V., Shumilov, E., Shvorob, A., Siedenburg, T., Son, D., Smith, B., Spillantini, P., Steuer, M., Stickland, D.P., Stone, A., Stoyanov, B., Straessner, A., Sudhakar, K., Sultanov, G., Sun, L.Z., Suter, H., Swain, J.D., Szillasi, Z., Sztaricskai, T., Tang, X.W., Tauscher, L., Taylor, L., Tellili, B., Timmermans, Charles, Ting, Samuel C.C., Ting, S.M., Tonwar, S.C., Toth, J., Tully, C., Tung, K.L., Uchida, Y., Ulbricht, J., Valente, E., Vesztergombi, G., Vetlitsky, I., Vicinanza, D., Viertel, G., Villa, S., Vivargent, M., Vlachos, S., Vodopianov, I., Vogel, H., Vogt, H., Vorobev, I., Vorobov, A.A., Vorvolakos, A., Wadhwa, M., Wallraff, W., Wang, M., Wang, X.L., Wang, Z.M., Weber, A., Weber, M., Wienemann, P., Wilkens, H., Wu, S.X., Wynhoff, S., Xia, L., Xu, Z.Z., Yamamoto, J., Yang, B.Z., Yang, C.G., Yang, H.J., Yang, M., Ye, J.B., Yeh, S.C., Zalite, A., Zalite, Yu., Zhang, Z.P., Zhu, G.Y., Zhu, R.Y., Zichichi, A., Zilizi, G., Zoller, M.
    Publicado 2000
    Enlace del recurso
    Enlace del recurso
  8. 702448
    “….: Grant/Research Support|Iterum Therapeutics Limited: Grant/Research Support|Kaizen Bioscience, Co.: Grant/Research Support|KBP Biosciences USA: Grant/Research Support|Matinas Biopharma: Grant/Research Support|Meiji Seika Pharma Co., Ltd.: Grant/Research Support|Melinta Therapeutics: Grant/Research Support|Menarini Ricerche S.p.A.: Grant/Research Support|Mutabilis: Grant/Research Support|Nabriva Therapeutics AG: Grant/Research Support|Paratek Pharmaceuticals, Inc.: Grant/Research Support|Qpex Biopharma: Grant/Research Support|Sfunga Therapeutics: Grant/Research Support|Spero Therapeutics: Grant/Research Support|Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support|Theravance: Grant/Research Support|tranScrip Partners: Grant/Research Support|University of Wisconsin: Grant/Research Support|Utility Therapeutics: Grant/Research Support|ValanBio Therapeutics Inc.: Grant/Research Support|VenatoRx: Grant/Research Support Catharine Vincent, Ph.D., Adagio Therapeutics: Grant/Research Support|Albany Medical College: Grant/Research Support|Amplyx Pharmaceuticals: Grant/Research Support|AN2: Grant/Research Support|Antabio SAS: Grant/Research Support|Arcutis Biotherapeutics: Grant/Research Support|B. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 702449
  10. 702450
  11. 702451
    “…All researches that could answer the research question were included, the limitation of this study was the difficulty in finding authors whose research is centre in the indicators of family hazard for children and young people, with a The vast literature where risk and danger coexist. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 702452
    “…Studies on wider determinants of behaviors in medical treatment seeking for diarrheal illnesses in poor resource settings are limited. However, the challenges are continuing and, there is a gap in research work about it in the Gambia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 702453
    “…The cost-effectiveness of these biologics has been estimated using disease burden data from global meta-analyses, but these are sensitive to the detailed age breakdown of paediatric RSV disease, for which there have previously been limited data. METHODS: We use original hospital-based incidence data from South Africa (ZAF) and Kenya (KEN) collected between 2010 and 2018 of RSV-associated acute respiratory infection (ARI), influenza-like illness (ILI), and severe acute respiratory infection (SARI) as well as deaths with monthly age-stratification, supplemented with data on healthcare-seeking behaviour and costs to the healthcare system and households. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 702454
    “…CONCLUSION: BPI-9016M showed manageable safety profile in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic NSCLC, but showed limited efficacy. TRIAL REGISTRATION: Clinicaltrials.gov NCT02929290 (11/10/2016). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 702455
    “…However, there are few studies documenting the burden of mental health problems and even fewer mental health services in the region. In relation to the limited body of knowledge, the present study aims to determine the psychological well-being of adolescents and to assess the risks and associated factors of mental health problems among adolescents in the context of COVID-19 pandemic in Kenya. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 702456
    “…Previous reviews focused on limited sets of MAUIs and psychometric properties, and only on evidence from studies that directly aimed to conduct psychometric assessments. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 702457
    “…However, the feasibility and efficacy of HPSP were currently only evidenced by studies with a limited sample size, so this study aimed to provide a comprehensive assessment through a systematic review and meta-analysis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 702458
    por Dong, Bo
    Publicado 2023
    “…While existing research suggests that provincial pooling of basic health insurance affects the health of participants, the findings are not yet consistent, and there is limited research on the specific pathways of impact between the two. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 702459
    “…BACKGROUND: Traditional systemic immunosuppressants and advanced therapies improve signs and symptoms of moderate-to-severe atopic dermatitis (AD). However, data are limited in severe and/or difficult-to-treat AD. In the phase 3 JADE COMPARE trial of patients with moderate-to-severe AD receiving background topical therapy, once-daily abrocitinib 200 mg and 100 mg showed significantly greater reductions in the symptoms of AD than placebo and significantly greater improvement in itch response (with abrocitinib 200 mg) than dupilumab at week 2. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 702460
    “…The genetic variability of an antigen may limit the effectiveness of its application as a serological surveillance tool and in vaccine development and, therefore, the aim of this study was to investigate the genetic diversity of pvetramp11.2 in parasite populations from Amazonian regions and worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS